LYTIR

Company · EXOZ

eXoZymes Inc.

Name as listed on its exchange; filed with the SEC as EXOZYMES INC.

Nasdaq's symbol directory lists EXOZ on Nasdaq as “eXoZymes Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($6K); insiders sold on 1 occasion ($19K); 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $6K in total; Insider sales: $19K in total.Aug: Insider purchases $6KOct: Insider sales $19KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $6KInsider sales below: $19K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Perriman Damien Alan, Chief Commercial Officer sold on 1 day latest Oct 12, 2026 sold $19K
  2. Michael Heltzen, Chief Executive Officer bought on 2 days latest Aug 26, 2026 bought $6K
Every trade (3)
  1. SELLPerriman Damien Alan, Chief Commercial Officer sold Oct 12, 2026 3,729 shares filing $19K
  2. BUYMichael Heltzen, Chief Executive Officer bought Aug 26, 2026 505 shares 3 legs combined filing $4K
  3. BUYMichael Heltzen, Chief Executive Officer bought Aug 25, 2026 350 shares 2 legs combined filing $3K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Oct 9, 2026
  2. Other events filing Sep 18, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.